ArticleTranslational cancer research2021

Phase 1 dose-escalation study of apatinib and irinotecan in esophageal squamous cell carcinoma patients.

Jun Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.